Generics 37

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Deferasirox manufacturers

37 products found

Filters

37 products found

deferasirox

Tablets, orally disintegrating (ODT) 125mg, 250mg, 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Technology transfer
Manufacturer #337
A pharmaceutical manufacturer based in the EU that has been active in 90+ countries selling its products in the EU, Africa, North America, Middle East, and Asia for 30+ years. Key production lines are Rx and OTC. Main therapeutic areas include diabetes, CNS, and dermatology. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 5 days

deferasirox

Tablets, orally disintegrating (ODT) 125 mg, 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Bahrain , Egypt , Iran , Iraq , Israel , Kuwait , Morocco , Oman , Saudi Arabia , Tunisia , United Arab Emirates , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

deferasirox

Tablets 90mg,180mg, 360mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17457
In the past fifty years, the company has reached significant milestones—a result of enviable performance, strict adherence to the highest ethical and operational standards, and full compliance with global regulatory authorities. During this journey, they have emerged as one of the leading in-house development partners based in Europe, specializing in the development, registration, manufacturing, and life-cycle management of highly complex pharmaceutical technologies and generic formulations.

Manufacturer usually replies in 26 days

deferasirox

Tablets, orally disintegrating (ODT) 125 mg, 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
EU GMP, Canada
Comments
Reference product : Exjade (Novartis)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

deferasirox

Tablets, film coated 90 mg, 180 mg, 360 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Exjade® FC Tablets (Novartis)
Manufacturer #18226

Manufacturer usually replies in 7 days

deferasirox

Tablets, film coated 90 mg, 180 mg, 360 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, Saudi Arabia, Ukraine
Unavailable markets
Bulgaria , Costa Rica , Germany
Registered in
Swaziland , Turkey
Available for
Licensing with supply
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

deferasirox

Tablets 90mg,180mg,360mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #281
It is a leading European pharmaceutical firm that strives to create a powerful global brand with innovative goods and services, as well as bold and pioneering activities, by working passionately to heal the lives they touch. The business was founded in the 1900s. In the interest of public health and the national economy, the firm launched the project to promote public awareness about the unintentional use of medications.

Manufacturer usually replies in 8 days

deferasirox

Tablets, soluble 125mg,250mg,500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #281
It is a leading European pharmaceutical firm that strives to create a powerful global brand with innovative goods and services, as well as bold and pioneering activities, by working passionately to heal the lives they touch. The business was founded in the 1900s. In the interest of public health and the national economy, the firm launched the project to promote public awareness about the unintentional use of medications.

Manufacturer usually replies in 8 days

deferasirox

Tablets, film coated 90 mg, 180 mg , 360 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Turkey , Vietnam , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

deferasirox

Tablets, film coated 90 mg, 180 mg, 360 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Jadenu (Novartis)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

deferasirox

Tablets 90 mg , 180 mg, 360 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #13095

Manufacturer usually replies in 5 days

deferasirox

Tablets, effervescent 125 mg, 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
Turkey
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Exjade
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.

Manufacturer usually replies in 7 days

deferasirox

Tablets 100 mg, 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

deferasirox

Tablets, film coated 90mg, 180mg, 360mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #10281
It is part of the pharmaceutical and medicine manufacturing industry and is located in Europe. The company's purpose is to be on the lookout for new ways to improve human health and quality of life. Respect for the individual, openness to progress, reasonable power, and respect for the work, workplace, and community are the company's principles.

Manufacturer usually replies in 5 days

deferasirox

Tablets 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

deferasirox

Tablets, effervescent 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18434

Manufacturer usually replies in 4 days

deferasirox

Tablets 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Registered in
Argentina
Available for
Licensing with supply, Distribution only
Manufacturer #15733
One of the leading manufacturers in cosmetic and medicinal products in the South American Continent. The company has been committed since 1990-is to developing and manufacturing high-quality products that allow healing and improve someone’s life. They are a major exporter of its therapies to different regions such as Latin America and Asia. Medicine is manufactured for pain, gastroenterology, hepatology, and cardiology.

Manufacturer usually replies in 8 days

deferasirox

Tablets, immediate release (IR) 90 mg, 180 mg, 360 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
WHO, PICS, MY
Unavailable markets
Brunei , Malaysia , Singapore
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #25654

Manufacturer usually replies in 2 days

deferasirox

Tablets 90, 180, 360 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10897
A pharmaceutical manufacturer based in Asia that is active in 80+ countries selling its products in Europe, North America, Africa, the Middle East, CIS, LATAM, and Asia for 40+ years. The company's production lines are WHO GMP-compliant. The main dosage forms are tablets, capsules, dry syrups, suspensions, and injections. The main therapeutic areas include antifungal, analgesics, and psychotropics.

Manufacturer usually replies in 12 days

deferasirox

Tablets, orally disintegrating (ODT) 125 mg, 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Unavailable markets
Vietnam
Manufacturer #7170
A pharmaceutical manufacturer based in Europe that has been active in 20+ countries selling its products in Europe, CIS, Middle East, Africa, and LATAM for 60+ years. The main therapeutic areas include cardiology, CNS, and rare diseases. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 7 days

Want to view all 37 products? Create your free account today!

Deferasirox Manufacturers

Deferasirox is an iron chelator belonging to a class of medications called Iron-Chelating agents. Deferasirox is the first oral medication approved by FDA for chronic iron overload in patients receiving blood transfusion for a prolonged use and this medication is also used to treat high levels of iron in people with certain blood disorders who actually do not require blood transfusion. Blood transfusion is often needed in few types of blood diseases such as anemia, sickle cell disease, which leads to additional iron that may build up in the body and cause problems such as diabetes, liver disease, heart failure etc, and deferasirox is used to eliminate the additional iron from the bloodstream and reduces the risk of these diseases.

Before using deferasirox, the risk of taking the drug must be weighed against the benefits it provides. It is always recommended to consult a physician before taking deferasirox as this medication may interact with other drugs or health problems.

Deferasirox is advised as a prescription product as well as generic prescription product. Manufacturers market deferasirox under the Brand name of Exjade, Jadenu. Deferasirox is available in a dosage form of tablet, granules, tablet for suspension in dosage strengths of 90 mg, 125 mg, 250 mg, 500 mg which is taken by mouth once daily on an empty stomach half an hour before meals. Deferasirox tablets are supplied as round, white, film coated tablets imprinted with the first letter of brand name and strength on one side and manufacturer name on the other side in a bottle of 30 tablets.

Deferasirox therapy should be considered only when a patient has proof of iron overload over a long-term blood transfusion, the recommended initial dose of deferasirox in transfusional iron overload patients with 2 years of age and older with estimated glomerular filtrate rate greater than 60 mL/min/1.73 m2 is 20 mg per kg body weight given orally once daily. The recommended initial dose of deferasirox in iron overload in non-transfusion-dependent thalassemia syndromes in patients with eGFR greater than 60 mL/min/1.73 m2 is 10 mg per kg body weight given orally once daily. Deferasirox Tablets are recommended to be stored at 25° C (77° F), in well closed containers with excursions permitted to 15° C to 30° C (59° F to 86° F) with protection from moisture.

Wholesale Price of Deferasirox

The wholesale price for 30 units of 90 mg deferasirox oral tablet is $ 966 with per unit cost comes at $ 32.21 The cost for deferasirox 180 mg oral tablet is around $ 1922 for a supply of 30 tablets with per unit cost available for as low as $ 64 The cost for deferasirox oral granule for reconstitution 90 mg is around $ 914 for a supply of 30 tablets with per unit cost available for as low as $ 30.47

Deferasirox - Mechanism of Action

Deferasirox works by binding to iron in the bloodstream by forming a stable complex which is eliminated through kidneys.

Finding Deferasirox Manufacturers and Suppliers

To find a trustful partner in any business is one of the tedious tasks and to overcome that challenge and to make one’s work / life easy in finding the trustful and suitable manufacturer and supplier of Deferasirox one can visit the Pipelinepharma website which helps the buyer in finding the dependable manufacturers and suppliers of Deferasirox. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects owner with the buyer for the business advancement. One can filter the product names in unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and many more.